Mayo Clinic, nonprofit partner on data-driven research collaborative for chronic diseases, COVID-19

Rochester, Minn.-based Mayo Clinic has partnered with Mitre Corp., a nonprofit that operates federally funded research and development centers, to further research focused on improving outcomes for oncology, cardiology and COVID-19 patients.

Advertisement

Researchers will use common data standards to develop automated platforms to better serve patients with chronic diseases. The collaborative effort also seeks to create the mCOVID platform, which will be designed to help mitigate the spread of COVID-19 and can be adapted for use during future epidemics.

“Defining common data elements will help transform how we approach cancer and chronic disease, facilitating additional research,” John Halamka, MD, president of Mayo Clinic Platform, said in an Aug. 26 news release.

Mayo Clinic and Mitre serve as co-chairs of the COVID-19 Healthcare Coalition, a collaborative of more than 1,000 institutions working together to gather data, pull insights and conduct research on COVID-19. The two organizations’ recent partnership marks another effort to enhance digital health capabilities and improve patient outcomes.

More articles on digital transformation:
UCSF Medicine’s new $1.5M innovation fund focuses 1st project on telemedicine training
Optum in the past 100 days: 6 things to know
Presbyterian Healthcare Services CIO on IT team’s new operating model: We have to deliver more quickly than ever before

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.